$30.61
4.61% today
Nasdaq, Sep 19, 06:15 pm CET
ISIN
US14167L1035
Symbol
CDNA
Sector
Industry

CareDx, Inc. Stock price

$29.26
-4.73 13.92% 1M
+19.37 195.85% 6M
+17.26 143.83% YTD
+21.35 269.91% 1Y
-34.55 54.15% 3Y
+5.39 22.58% 5Y
+20.55 235.94% 10Y
Nasdaq, Closing price Wed, Sep 18 2024
-0.86 2.86%
ISIN
US14167L1035
Symbol
CDNA
Sector
Industry

Key metrics

Market capitalization $1.54b
Enterprise Value $1.35b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 4.53
P/S ratio (TTM) P/S ratio 5.19
P/B ratio (TTM) P/B ratio 5.82
Revenue growth (TTM) Revenue growth -3.95%
Revenue (TTM) Revenue $297.08m
EBIT (operating result TTM) EBIT $-76.01m
Free Cash Flow (TTM) Free Cash Flow $-21.41m
Cash position $228.87m
EPS (TTM) EPS $-2.99
P/E forward negative
P/S forward 4.74
EV/Sales forward 4.14
Short interest 8.31%
Show more

Is CareDx, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

CareDx, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a CareDx, Inc. forecast:

5x Buy
56%
3x Hold
33%
1x Sell
11%

Analyst Opinions

9 Analysts have issued a CareDx, Inc. forecast:

Buy
56%
Hold
33%
Sell
11%

Financial data from CareDx, Inc.

Jun '24
+/-
%
Net Profit -1.39 -1.39
94% 94%
-2%
Depreciation and Amortization 4.96 4.96
0% 0%
5%
Stock Compensation 13 13
4% 4%
14%
Operating Cash Flow 19 19
3,890% 3,890%
21%
Investments 1.79 1.79
24% 24%
2%
Dividend Paid - -
-
-
Free Cash Flow 17 17
700% 700%
19%

In millions USD.

Don't miss a Thing! We will send you all news about CareDx, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CareDx, Inc. Stock News

Neutral
Business Wire
6 days ago
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced that, on September 12, 2024, CareDx granted an option to purchase 100,651 shares of CareDx...
Neutral
Business Wire
6 days ago
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced that, as an inducement material to entering into employment with CareDx, on September 12,...
Neutral
Business Wire
about one month ago
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company™ – today announced that the Centers for Medicare and Medicaid Services (CMS) has announced its plan to retire a draft LCD that would have restricted coverage for non-invasive blood-based surveillance testing for allograft rejection. Combined with the February 2024 removal of restrictive language in the accom...
More CareDx, Inc. News

Company Profile

CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Head office United States
CEO John Hanna
Employees 643
Founded 1998
Website www.caredx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today